These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22239591)

  • 1. Polyunsaturated fatty acids in emerging psychosis.
    Mossaheb N; Schloegelhofer M; Schaefer MR; Fusar-Poli P; Smesny S; McGorry P; Berger G; Amminger GP
    Curr Pharm Des; 2012; 18(4):576-91. PubMed ID: 22239591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyunsaturated fatty acids in emerging psychosis: a safer alternative?
    Schlögelhofer M; Amminger GP; Schaefer MR; Fusar-Poli P; Smesny S; McGorry P; Berger G; Mossaheb N
    Early Interv Psychiatry; 2014 Aug; 8(3):199-208. PubMed ID: 24861004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
    Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
    Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.
    Amminger GP; Mechelli A; Rice S; Kim SW; Klier CM; McNamara RK; Berk M; McGorry PD; Schäfer MR
    Transl Psychiatry; 2015 Jan; 5(1):e495. PubMed ID: 25585167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology.
    Bozzatello P; De Rosa ML; Rocca P; Bellino S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.
    Markulev C; McGorry PD; Nelson B; Yuen HP; Schaefer M; Yung AR; Thompson A; Berger G; Mossaheb N; Schlögelhofer M; Smesny S; de Haan L; Riecher-Rössler A; Nordentoft M; Chen EYH; Verma S; Hickie I; Amminger GP
    Early Interv Psychiatry; 2017 Oct; 11(5):418-428. PubMed ID: 26279065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acids and peripheral artery disease.
    Grenon SM; Hughes-Fulford M; Rapp J; Conte MS
    Vasc Med; 2012 Feb; 17(1):51-63. PubMed ID: 22363018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia.
    Akter K; Gallo DA; Martin SA; Myronyuk N; Roberts RT; Stercula K; Raffa RB
    J Clin Pharm Ther; 2012 Apr; 37(2):132-9. PubMed ID: 21501206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Polyunsaturated Fatty Acids (PUFAs) on Impulsive Behaviours and Aggressiveness in Psychiatric Disorders.
    Bellino S; Bozzatello P; Badino C; Mantelli E; Rocca P
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial.
    Armando M; De Crescenzo F; Vicari S; Digilio MC; Pontillo M; Papaleo F; Amminger GP
    Early Interv Psychiatry; 2016 Oct; 10(5):390-6. PubMed ID: 25345540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis.
    Susai SR; Healy C; Mongan D; Heurich M; Byrne JF; Cannon M; Cagney G; Wynne K; Markulev C; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Street R; Thompson A; Yung AR; Nelson B; McGorry PD; Föcking M; Amminger GP; Cotter D
    Transl Psychiatry; 2022 Oct; 12(1):454. PubMed ID: 36307392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders.
    Tan ML; Ho JJ; Teh KH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009398. PubMed ID: 23235675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Evidence on the Role of Dietary PUFAs in Cancer Development and Prevention.
    D'Archivio M; Scazzocchio B; Vari R; Santangelo C; Giovannini C; Masella R
    Curr Med Chem; 2018; 25(16):1818-1836. PubMed ID: 29210633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychosis prevention: expectations met].
    Bechdolf A; Peukert R
    Psychiatr Prax; 2011 Feb; 38(2):58-60. PubMed ID: 21394689
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommendations of the Spanish Menopause Society on the consumption of omega-3 polyunsaturated fatty acids by postmenopausal women.
    Sánchez-Borrego R; von Schacky C; Osorio MJA; Llaneza P; Pinto X; Losa F; Navarro MC; Lubián D; Mendoza N
    Maturitas; 2017 Sep; 103():71-77. PubMed ID: 28778336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyunsaturated fatty acid supplementation for schizophrenia.
    Joy CB; Mumby-Croft R; Joy LA
    Cochrane Database Syst Rev; 2003; (2):CD001257. PubMed ID: 12804400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?
    Mossaheb N; Schäfer MR; Schlögelhofer M; Klier CM; Cotton SM; McGorry PD; Amminger GP
    Schizophr Res; 2013 Aug; 148(1-3):163-7. PubMed ID: 23778032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.